Coherus BioSciences’ $1.1 Billion Immuno-Oncology Collaboration with Junshi Biosciences

Ropes & Gray represented Coherus BioSciences in the transaction. Coherus BioSciences, Inc. entered into a $1.1 billion immune-oncology collaboration agreement with Junshi Biosciences directed towards the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Level 3 Financing’s $900 Million High?Yield Sustainability?Linked Senior Notes Offering

Cravath represented the initial purchasers on the offering. Level 3 Financing, Inc. executed its $900 million 144A/Reg. S high-yield sustainability-linked senior notes, guaranteed by Level 3...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here